EN
抗体药类似物
Research Grade Dilpacimab
All
TD-HV571046_1.jpg
TD-HV571046_2.jpg
  • CatalogTD-HV571046
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,ABT-165,PR-1283233,CAS:1791420-09-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Dilpacimab


Catalog No. TD-HV571046
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Delta-like protein 4, Drosophila Delta homolog 4, Delta4, DLL4, Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9NR61 & P15692
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,ABT-165,PR-1283233,CAS:1791420-09-1
Background Dilpacimab (ABT165) is a potent dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways.. Dilpacimab can be used in research of cancer.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV571046_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Dilpacimab.
TD-HV571046_2.jpg
Bioactivity
 
Detects VEGFA in indirect ELISAs.